Actively Recruiting
Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke
Led by Xijing Hospital · Updated on 2025-12-04
60
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, randomized, double-blind, sham-controlled trial, to determine the efficacy and safety of cTBS in treating patients with acute ischemic stroke after endovascular treatment.
CONDITIONS
Official Title
Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with acute anterior circulation ischemic stroke aged between 18 and 80 years old
- Imaging shows infarction caused by occlusion of the terminal internal carotid artery or M1/M2 segment of the middle cerebral artery
- Head CT within 24 hours of onset shows ASPECT score of 6 or higher and meets thrombectomy criteria
- Pre-stroke modified Rankin Scale score of 1 or less
- NIH Stroke Scale score between 6 and 25 before thrombectomy
- Successful vascular recanalization with mTICI score greater than 2b/3
- Signed informed consent form
You will not qualify if you...
- Contraindications to transcranial magnetic stimulation such as metallic foreign objects in the head, pacemakers, implantable drug pumps, cochlear implants
- Epilepsy, increased intracranial pressure, tumors, acute cerebral hemorrhage, or other severe neurological diseases
- Severe functional impairment of heart, liver, or kidneys
- Head CT/MRI shows midline shift, significant mass effect, or planned surgical intervention
- Acute cerebral infarction on both sides of the brain
- Pregnancy or breastfeeding
- Severe mental disorders or dementia preventing cooperation with follow-up
- Other severe diseases with expected survival less than 90 days
- Participation in other interventional clinical studies within 30 days before this study or after condition onset
- Inability to cooperate with informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032
Actively Recruiting
Research Team
J
Jingjing Zhao, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here